Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302)-Reference-Cited by-同舟云学术

Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302)

Published:2020-10-10 Issue:23 Volume:9 Page:8884-8894
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Oswald Laura B.¹^ORCID,Lee Ju‐Whei²^ORCID,Argiris Athanassios³^ORCID,Webster Kimberly A.¹^ORCID,Forastiere Arlene A.⁴^ORCID,Cella David¹^ORCID

Affiliation:

1. Department of Medical Social Sciences Northwestern University Feinberg School of Medicine Chicago IL USA

2. Department of Data Sciences Dana‐Farber Cancer InstituteECOG‐ACRIN Biostatistics Center Boston MA USA

3. Department of Medical Oncology Thomas Jefferson University Hospital Philadelphia PA USA

4. Department of Oncology Johns Hopkins University Baltimore MD USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3506

Reference26 articles.

1. Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

2. Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy

3. A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐reported outcome measures for dysphagia in head and neck cancer: A systematic review and appraisal of content validity and internal structure;Head & Neck;2024-02-15

2. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Guidance for Use in Research and Clinical Practice;Handbook of Quality of Life in Cancer;2022

3. Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index‐10 (FHNSI‐10);Health Science Reports;2021-10-19

4. Defining the needs of patients with recurrent and/or metastatic head and neck cancer: An expert opinion;Critical Reviews in Oncology/Hematology;2021-01